102 related articles for article (PubMed ID: 20230865)
21. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications.
Zheng J; Perkins G; Kirilova A; Allen C; Jaffray DA
Invest Radiol; 2006 Mar; 41(3):339-48. PubMed ID: 16481918
[TBL] [Abstract][Full Text] [Related]
22. Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 Tesla.
Loai Y; Sakib N; Janik R; Foltz WD; Cheng HL
Mol Imaging; 2012 Apr; 11(2):166-75. PubMed ID: 22469244
[TBL] [Abstract][Full Text] [Related]
23. Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI.
Guenoun J; Koning GA; Doeswijk G; Bosman L; Wielopolski PA; Krestin GP; Bernsen MR
Cell Transplant; 2012; 21(1):191-205. PubMed ID: 21929868
[TBL] [Abstract][Full Text] [Related]
24. In vivo MRI visualization of different cell populations labeled with PARACEST agents.
Ferrauto G; Delli Castelli D; Terreno E; Aime S
Magn Reson Med; 2013 Jun; 69(6):1703-11. PubMed ID: 22837028
[TBL] [Abstract][Full Text] [Related]
25. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
[TBL] [Abstract][Full Text] [Related]
26. Lanthanide complexes of triethylenetetramine tetra-, penta-, and hexaacetamide ligands as paramagnetic chemical exchange-dependent saturation transfer contrast agents for magnetic resonance imaging: nona- versus decadentate coordination.
Burdinski D; Pikkemaat JA; Lub J; de Peinder P; Nieto Garrido L; Weyhermüller T
Inorg Chem; 2009 Jul; 48(14):6692-712. PubMed ID: 19507818
[TBL] [Abstract][Full Text] [Related]
27. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
[TBL] [Abstract][Full Text] [Related]
28. MR and fluorescent imaging of low-density lipoprotein receptors.
Li H; Gray BD; Corbin I; Lebherz C; Choi H; Lund-Katz S; Wilson JM; Glickson JD; Zhou R
Acad Radiol; 2004 Nov; 11(11):1251-9. PubMed ID: 15561572
[TBL] [Abstract][Full Text] [Related]
29. Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model.
Zheng J; Jaffray D; Allen C
Mol Pharm; 2009; 6(2):571-80. PubMed ID: 19298061
[TBL] [Abstract][Full Text] [Related]
30. Evidence for in vivo macrophage mediated tumor uptake of paramagnetic/fluorescent liposomes.
Castelli DD; Terreno E; Cabella C; Chaabane L; Lanzardo S; Tei L; Visigalli M; Aime S
NMR Biomed; 2009 Dec; 22(10):1084-92. PubMed ID: 19569084
[TBL] [Abstract][Full Text] [Related]
31. An MRI Method To Map Tumor Hypoxia Using Red Blood Cells Loaded with a pO2-Responsive Gd-Agent.
Di Gregorio E; Ferrauto G; Gianolio E; Lanzardo S; Carrera C; Fedeli F; Aime S
ACS Nano; 2015 Aug; 9(8):8239-48. PubMed ID: 26234938
[TBL] [Abstract][Full Text] [Related]
32. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
33. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer.
Terreno E; Delli Castelli D; Violante E; Sanders HM; Sommerdijk NA; Aime S
Chemistry; 2009; 15(6):1440-8. PubMed ID: 19115311
[TBL] [Abstract][Full Text] [Related]
34. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
[TBL] [Abstract][Full Text] [Related]
35. Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling.
Digilio G; Menchise V; Gianolio E; Catanzaro V; Carrera C; Napolitano R; Fedeli F; Aime S
J Med Chem; 2010 Jul; 53(13):4877-90. PubMed ID: 20533827
[TBL] [Abstract][Full Text] [Related]
36. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
37. A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent.
Cron GO; Wallace JC; Stevens WD; Fortin T; Pappas BA; Wilkins RC; Kelcz F; Santyr GE
Magn Reson Imaging; 2005 Jun; 23(5):619-27. PubMed ID: 16051036
[TBL] [Abstract][Full Text] [Related]
38. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results.
Mäurer J; Strauss A; Ebert W; Bauer H; Felix R
Melanoma Res; 2000 Feb; 10(1):40-6. PubMed ID: 10711639
[TBL] [Abstract][Full Text] [Related]
40. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.
Kircher MF; Allport JR; Graves EE; Love V; Josephson L; Lichtman AH; Weissleder R
Cancer Res; 2003 Oct; 63(20):6838-46. PubMed ID: 14583481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
